In a short period of time, TransCelerate has achieved unprecedented progress, delivering tangible impact to benefit the broader biopharmaceutical industry. All this would not have been achievable without the active engagement and sponsorship from some of the most senior leaders in the R&D ecosystem.
In just a few years, our leaders have made significant strides toward our goal of making clinical development more efficient. TransCelerate leadership has an unwavering dedication to assessing, refining, and creating processes to make the drug development environment efficient, safe, and innovative.
CEO, TransCelerate BioPharma Inc.
Allison Cuff Shimooka
COO, TransCelerate BioPharma Inc.
Karin Kramer Nielsen
Oversight Committee Chair, TransCelerate
Corporate Vice President Data Management, Novo Nordisk
Pharmacovigilance Steering Committee Chair, TransCelerate
Global Head, PV & Scientific Development, Roche
Corporate Treasurer, TransCelerate
SVP, Head of Global Clinical Trial Operations, Merck
Corporate Secretary, TransCelerate
Chief Safety Officer, Vice President, and Head of Global Medical Safety for the Janssen Pharmaceutical Companies of Johnson & Johnson
Vice President, Global Communications & Engagement, TransCelerate BioPharma Inc.
Vice President, Portfolio Management, TransCelerate BioPharma, Inc.
Vice President, Portfolio Management, TransCelerate BioPharma Inc.
Executive Director, Portfolio Management,
TransCelerate BioPharma Inc.
Executive Director, Finance & Administration
TransCelerate BioPharma Inc.
Board Of Directors
Chair of the Board, TransCelerate BioPharma; Head, Global Development Janssen Research & Development, LLC
Vice-Chair of the Board, TransCelerate BioPharma; Head, Global Development Operations, Novartis
Senior Vice President, Global Clinical Development, Chief Medical Officer, MSD
Chief Medical Officer, Global Head of Development, Sanofi
Corporate Senior Vice President and Head of Global Clinical Development & Operations at Boehringer Ingelheim
SVP, Head of Development, GSK
Senior Vice President and Head of Clinical Development & Operations, Pfizer
Martin Holst Lange
Executive Vice President, Development, Novo Nordisk A/S
Head of Global Development and Clinical Operations, Pharmaceuticals Research & Development, Bayer
Senior Vice President, Head of Global Development Operations, Merck KGaA
Senior Vice President, Development Operations and Portfolio Management, Regeneron
EVP and CMO, UCB
Chief Medical Officer and Chief Development Officer Oncology, AstraZeneca
Senior Vice President, CDDA, China & Japan Medical, Eli Lilly and Company
SVP, Global Head of Pharma Regulatory and Policy, Roche
Director, Vice President of the Board, Shionogi & Co., Ltd.
Head of Clinical Development, BMS
Chief Medical Officer, Astellas
Senior Vice President of Development & Regulatory Affairs and Chief Medical Officer, AbbVie